Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nucleic acid vaccine for kio herpesvirus

A koi herpes virus and nucleic acid vaccine technology, applied in the biological field, can solve the problems of carp death, carp breeding industry attack, koi herpes virus disease can not play a complete immune protection effect, achieve small immune dose, maintain ecological stability Sexuality, the effect of reducing the amount of drug use

Inactive Publication Date: 2013-03-27
JILIN AGRICULTURAL UNIV
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the disease is more common in carp farming in my country, causing a large number of carp deaths and bringing almost devastating blows to the carp farming industry.
Although there are a variety of traditional vaccines that can be used for immune prevention of diseases, the production practice and our experimental research results show that the use of inactivated vaccines to immunize and prevent koi herpes virus disease cannot achieve complete immune protection. There is no report on the isolation or research of KHV attenuated strain virus, so there is an urgent need for a new vaccine for this virus to come out

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid vaccine for kio herpesvirus
  • Nucleic acid vaccine for kio herpesvirus
  • Nucleic acid vaccine for kio herpesvirus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Embodiment 1: Cloning and identification of ORF81 gene

[0022] 1. Design ORF81 gene amplification primers

[0023] According to the KHV-I strain ORF81 gene sequence registered on GenBank, primers were designed using the software Primer Premiers 5.0, and the upstream primer was: F15′- CCCGG GATGGCAGTCACCAAAGCT-3′, the downstream primer is: F25′- TCTAGA TCACCATCTTGCCGG-3′, two restriction enzyme cutting sites (underlined parts) of Sma Ⅰ and Xba Ⅰ were introduced respectively, and the primers were synthesized by Shanghai Sangon Bioengineering Technology Service Co., Ltd.

[0024] 2. PCR amplification and identification of ORF81 gene

[0025] Using KHV nucleic acid DNA as a template, the ORF81 gene was amplified by PCR. The reaction system is: F1, F2 (20pmol / μL) 0.5μL, 10×ExBuffer 2.5μL, dNTP 2μL, DNA 1μL, ExTaq enzyme 0.25μL, add sterilized water to make up to 25μL. The PCR reaction conditions were: pre-denaturation at 95°C, 5min; denaturation at 94°C, 40s; annealin...

Embodiment 2

[0027] Example 2: Construction and identification of pIRES-ORF81 recombinant eukaryotic expression plasmid

[0028] 1. Preparation of pIRES-neo plasmid

[0029] Take 5 μl of DH5α bacterial liquid containing pIRES-neo plasmid (purchased from Kingvik (China) Biotechnology Center), add it to 5 mL LB liquid medium containing ampicillin, and culture overnight at 37°C with 180r / min shaking. A small amount of plasmids were prepared according to the SDS alkaline lysis method of the molecular cloning operation guide (third edition).

[0030] 2. Digestion of pIRES-neo plasmid

[0031] The pIRES-neo plasmid was subjected to SmaI and XbaI double enzyme digestion, 1.0% agarose electrophoresis, and a large piece of enzyme digestion was recovered according to the instructions of the Tiangen company's agarose gel DNA recovery kit.

[0032] 3. Cloning of ORF81 gene in pIRES-neo plasmid

[0033] Use the agarose gel DNA recovery kit of Tiangen Company to recover and purify the PCR product of ...

Embodiment 3

[0037] Example 3: Expression of recombinant plasmid pIRES-ORF81 in MFC cells

[0038] 1. Mass extraction and purification of recombinant plasmids

[0039] Transform the identified positive pIRES-ORF81 plasmid into Escherichia coli DH5α competent cells, pick a single colony; inoculate it in 5 mL of LB liquid culture medium containing Amp+, culture with shaking at 37°C until logarithmic growth phase (OD600≈0.6); Take 1mL and inoculate it into 500mL LB liquid culture solution containing Amp to expand the culture. Centrifuge the above culture at 5000r / min for 10min, discard the supernatant, place it in a low-temperature freezer for several hours, and then use 200ml ice-precooled STE (0.1mol / L NaCl, 10mmol / L Tris-HCl pH8.0, 1mmol / L EDTA) to resuspend the bacterial pellet, and collect the bacteria by centrifugation as described above.

[0040] Refer to the Molecular Cloning Operation Guide (Third Edition) SDS alkaline lysis method to prepare a large number of plasmids and extract ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a nucleic acid vaccine for kio hepesvirus. The nucleic acid vaccine has high immunogenicity. The nucleic acid vaccine for the kio hepesvirus is a recombinant plasmid which is obtained by cloning an ORF81 gene into a eucaryon expression vector pIRES-neo. The nucleic acid vaccine for the kio hepesvirus has an effective preventative effect on a kio herpesvirus disease.

Description

technical field [0001] The invention relates to a koi herpes virus nucleic acid vaccine, which belongs to the field of biotechnology. Background technique [0002] Koi herpesvirus disease (KHVD) is a highly contagious and fatal disease caused by koi herpesvirus (KHV) in koi, carp and its common variants such as framed mirror carps. disease. [0003] The disease first broke out in the Magan Michael area of ​​Israel and the United States in 1998. In 2000, the disease spread to the United Kingdom, Germany and Belgium; in April 2002, the disease occurred in Indonesia, and the koi carp in Guangdong Province, China was suspected to have the disease; in the same year In December, Taiwan Province of my country confirmed that koi were infected with the disease; in October 2003, Japan confirmed that the disease had already existed in the country. At present, the disease is more common in carp culture in my country, causing a large number of carp deaths and bringing almost devastating...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/245A61K48/00A61P31/22
Inventor 周井祥王好李新伟张东鸣朱霞祖岫杰
Owner JILIN AGRICULTURAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com